Critical Care - Volume 9, issue 3

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cras neque tellus, ornare vel pulvinar luctus, vestibulum malesuada ante. Nullam pellentesque, ipsum vel fermentum tincidunt, velit neque molestie lacus, at iaculis purus mauris in nisl. Nullam vehicula imperdiet auctor. Mauris tempus, leo eget euismod condimentum, erat justo vehicula augue, vitae ornare elit felis nec libero. Etiam et quam sit amet metus dignissim dictum sed vitae purus. Phasellus gravida hendrerit risus vitae euismod. In elementum massa facilisis nulla pulvinar at pharetra leo pellentesque.

Electronic ISSN
1466-609X
Print ISSN
1364-8535

Abstract

In the February issue of Critical Care, Dr McKenzie and colleagues [1] describe a new method to differentiate between midazolam over-sedation and neurological damage in the intensive care unit by measuring 1-hydroxymidazolam glucuronide (1-OHMG), an active metabolite of midazolam in serum.

Journal: Critical Care, vol. 9, no. 3, 2005

Abstract

Introduction

Urinary recovery of enterally administered probes is used as a clinical test of intestinal mucosal permeability. Recently, evidence has been provided that the recovery of some but not all sugar probes is dependent on the amount of diuresis and renal function. The aim of this study was

Journal: Critical Care, vol. 9, no. 3, 2005

Abstract

Introduction

To achieve any possible positive effect on the intestinal mucosa cells it is important that probiotics adhere tightly onto the intestinal mucosa. It has been shown in healthy volunteers that Lactobacillus plantarum 299v (Lp 299v) (DSM 9843), a probiotic bacterium, given orally

Journal: Critical Care, vol. 9, no. 3, 2005